These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1811222)

  • 1. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
    Płaźnik A; Kostowski W
    Pol J Pharmacol Pharm; 1991; 43(4):301-22. PubMed ID: 1811222
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in animal models of depression and antidepressant response.
    Dalla C; Pitychoutis PM; Kokras N; Papadopoulou-Daifoti Z
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):226-33. PubMed ID: 20050844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic mediation effects of St John's wort in rats subjected to swim stress.
    Bano S; Dawood S
    Pak J Pharm Sci; 2008 Jan; 21(1):63-9. PubMed ID: 18166522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J
    Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
    [No Abstract]   [Full Text] [Related]  

  • 6. Stress-induced depression of basal motility: effects of antidepressant drugs.
    Zebrowska-Lupina I; Stelmasiak M; Porowska A
    Pol J Pharmacol Pharm; 1990; 42(2):97-104. PubMed ID: 2274476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.
    Sánchez C; Brennum LT; Stórustovu Sí; Kreilgård M; Mørk A
    Pharmacol Biochem Behav; 2007 Mar; 86(3):468-76. PubMed ID: 17303232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
    Li YC; Wang FM; Pan Y; Qiang LQ; Cheng G; Zhang WY; Kong LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):435-49. PubMed ID: 19302828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression.
    Kim SH; Han J; Seog DH; Chung JY; Kim N; Hong Park Y; Lee SK
    Life Sci; 2005 Jan; 76(11):1297-306. PubMed ID: 15642599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antidepressant on behavior and central catecholamine of depression-model rats.
    Kitayama I; Murase S; Koishizawa M; Kawaguchi S; Nomura J
    Yakubutsu Seishin Kodo; 1987 Dec; 7(4):433-6. PubMed ID: 3452275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of psychotropic drugs on the level and metabolism of noradrenaline in brain and behavior of rats.
    Herman ZS
    Arch Immunol Ther Exp (Warsz); 1970; 18(5):571-83. PubMed ID: 4395426
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on animal model of depression: review and perspective].
    Nomura S; Yamaoka K; Naitoh H
    Yakubutsu Seishin Kodo; 1989 Dec; 9(4):349-58. PubMed ID: 2698019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant agents. VI. 4,4-Diphenyl-1-methylcyclohexylamines.
    Carnmalm B; Persson ML; Ross SB; Ogren SO; Stjernström NE
    Acta Pharm Suec; 1975; 12(2):205-8. PubMed ID: 1163238
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1984; 39():327-43. PubMed ID: 6464831
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invivo antioxidant status: a putative target of antidepressant action.
    Zafir A; Ara A; Banu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
    Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic modulation of cortical rat noradrenergic system in the mechanism of action of antidepressant drugs.
    Brunello N; Mocchetti I; Volterra A; Cuomo V; Racagni G
    Psychopharmacol Bull; 1985; 21(3):379-84. PubMed ID: 4034853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.